1. Home
  2. AAPG vs BATRA Comparison

AAPG vs BATRA Comparison

Compare AAPG & BATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascentage Pharma Group International American Depository Shares

AAPG

Ascentage Pharma Group International American Depository Shares

N/A

Current Price

$30.00

Market Cap

2.9B

Sector

Health Care

ML Signal

N/A

Logo Atlanta Braves Holdings Inc. Series A

BATRA

Atlanta Braves Holdings Inc. Series A

HOLD

Current Price

$42.60

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAPG
BATRA
Founded
2009
1991
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.7B
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
AAPG
BATRA
Price
$30.00
$42.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$48.50
$58.00
AVG Volume (30 Days)
5.1K
54.7K
Earning Date
11-19-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$54,524,554.00
$723,307,000.00
Revenue This Year
N/A
$12.40
Revenue Next Year
$368.64
$6.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.62
52 Week Low
$16.50
$38.67
52 Week High
$48.45
$50.50

Technical Indicators

Market Signals
Indicator
AAPG
BATRA
Relative Strength Index (RSI) 50.39 45.95
Support Level $30.00 $42.05
Resistance Level $33.09 $43.59
Average True Range (ATR) 0.83 0.57
MACD 0.14 0.05
Stochastic Oscillator 72.07 36.13

Price Performance

Historical Comparison
AAPG
BATRA

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

Share on Social Networks: